Please try another search
Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea.
Name | Age | Since | Title |
---|---|---|---|
John S. Kang | - | - | Director |
Gyeong Jae Seo | 58 | 2003 | Managing Director and Director |
Nam-Joo Jung | 55 | 2010 | Director |
Sung-Kil Kang | 57 | 2004 | Managing Director and Director |
Dae-Ho Byun | 58 | - | Director |
Jung-Tae Park | 62 | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review